Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
MALDI mass spectrometry imaging is able to simultaneously determine the spatial distribution of hundreds of molecules directly from tissue sections, without labeling and without prior knowledge. Ultra-high mass resolution measurements based on Fourier-transform mass spectrometry have been utilized to resolve isobaric lipids, metabolites and tryptic peptides. Here we demonstrate the potential of 15T MALDI-FTICR MSI for molecular pathology in a mouse model of high-grade glioma. The high mass accuracy and resolving power of high field FTICR MSI enabled tumor specific proteoforms, and tumor-specific proteins with overlapping and isobaric isotopic distributions to be clearly resolved. The protein ions detected by MALDI MSI were assigned to proteins identified by region-specific microproteomics (0.8 mm 2 regions isolated using laser capture microdissection) on the basis of exact mass and isotopic distribution. These label free quantitative experiments also confirmed the protein expression changes observed by MALDI MSI and revealed changes in key metabolic proteins, which were supported by in-situ metabolite MALDI MSI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics
Ting, L., Rad, R., Gygi, S. P., & Haas, W. (2011) · Nature Methods · doi:10.1038/nmeth.1714 · Cited by 1,009
Research works printed but not linked: 45
- McDonnell, L. A. & Heeren, R. M. A. Imaging mass spectrometry. Mass Spectrom. Rev. 26, 606–643, doi:10.1002/mas.20124 (2007). · DOI · Paper page
- Maier, S. K. et al. Comprehensive identification of proteins from MALDI imaging. Mol. Cell. Proteomics 12, 2901–10, doi:10.1074/mcp.M113.027599 (2013). · DOI
- Nicolardi, S., Van Der Burgt, Y. E. M., Dragan, I., Hensbergen, P. J. & Deelder, A. M. Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera. J. Proteome Res. 12, 2260–2268, doi:10.1021/pr400136p (2013). · DOI · Paper page
- Heijs, B. et al. Comprehensive analysis of the mouse brain proteome sampled in mass spectrometry imaging. Anal. Chem. 87, 1867–1875, doi:10.1021/ac503952q (2015). · DOI
- Jones, E. E. et al. On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Anal. Chem. 86, 8303–8311, doi:10.1021/ac501937d (2014). · DOI
- Esteve, C., Tolner, E. a., Shyti, R., van den Maagdenberg, A. M. J. M. & McDonnell, L. a. Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue. Metabolomics 12, 30, doi:10.1007/s11306-015-0926-0 (2016). · DOI
- Mulder, I. A. et al. Funnel-freezing versus heat-stabilisation for the visualization of metabolites by mass spectrometry imaging in a mouse stroke model. Proteomics 16, 1652–1659, doi:10.1002/pmic.v16.11-12 (2016). · DOI
- McDonnell, L. a. et al. Peptide and protein imaging mass spectrometry in cancer research. J. Proteomics 73, 1921–1944, doi:10.1016/j.jprot.2010.05.007 (2010). · DOI · Paper page
- Poté, N. et al. Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas. Hepatology. Hepatology (Baltimore, Md.) 58, 983–994, doi:10.1002/hep.26433 (2013). · DOI
- Spraggins, J. M. et al. MALDI FTICR IMS of intact proteins: Using mass accuracy to link protein images with proteomics data. J. Am. Soc. Mass Spectrom 26, 947–985, doi:10.1007/s13361-015-1147-5 (2015). · DOI · Paper page
- Spraggins, J. M. et al. Next-generation technologies for spatial proteomics: Integrating ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR imaging mass spectrometry for protein analysis. Proteomics 16, 1678–1689, doi:10.1002/pmic.v16.11-12 (2016). · DOI · Paper page
- Rauniyar, N. & Yates, J. R. Isobaric Labeling-Based Relative Quanti fi cation in Shotgun Proteomics. J. Proteome Res. 13, 5293–5309, doi:10.1021/pr500880b (2014). · DOI · Paper page
- Louie, K. B. et al. Mass spectrometry imaging for in situ kinetic histochemistry. Sci. Rep. 3, 1656, doi:10.1038/srep01656 (2013). · doi:10.1038/srep01656
- Marie, S. K. N. & Shinjo, S. M. O. Metabolism and brain cancer. Clinics 66, 33–43, doi:10.1590/S1807-59322011001300005 (2011). · DOI
- Vannini, E. et al. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model. BMC Cancer 14, 449–458, doi:10.1186/1471-2407-14-449 (2014). · DOI
- Norris, J. L. et al. Processing MALDI mass spectra to improve mass spectral direct tissue analysis. Int. J. Mass Spectrom. 260, 212–221, doi:10.1016/j.ijms.2006.10.005 (2007). · DOI · Paper page
- McDonnell, L. A., van Remoortere, A., de Velde, N., van Zeijl, R. J. M. & Deelder, A. M. Imaging mass spectrometry data reduction: Automated feature identification and extraction. J. Am. Soc. Mass Spectrom. 21, 1969–1978, doi:10.1016/j.jasms.2010.08.008 (2010). · doi:10.1016/j.jasms.2010.08.008
- Mack, S. C., Hubert, C. G., Miller, T. E., Taylor, M. D. & Rich, J. N. An epigenetic gateway to brain tumor cell identity. Nat. Neurosci. 19, 10–19, doi:10.1038/nn.4190 (2015). · DOI
- Meier, J. L. Metabolic mechanisms of epigenetic regulation. ACS Chem. Biol. 8, 2607–2621, doi:10.1021/cb400689r (2013). · DOI · Paper page
- Melorose, J. et al. Metabolic regulation of histone post-translational modifications. ACS Chem. Biol. 8, 2607–2621 (2015).
- Shechter, D., Dormann, H. L., Allis, C. D. & Hake, S. B. Extraction, purification and analysis of histones. Nat. Protoc. 2, 1445–1457, doi:10.1038/nprot.2007.202 (2007). · DOI · Paper page
- Maleszewska, M. & Kaminska, B. Is glioblastoma an epigenetic malignancy? Cancers (Basel). 5, 1120–1139 (2013). · DOI · Paper page
- Arnaudo, A. M. & Garcia, B. a. Proteomic characterization of novel histone post-translational modifications. Epigenetics Chromatin 6, 24, doi:10.1186/1756-8935-6-24 (2013). · DOI · Paper page
- Lahiri, S. et al. In situ detection of histone variants and modifications in mouse brain using imaging mass spectrometry. Proteomics 16, 437–447, doi:10.1002/pmic.v16.3 (2016). · DOI
- Hardesty, W. M., Kelley, M. C., Mi, D., Low, R. M. & Caprioli, R. M. Protein signatures for survival and recurrence in metastatic melanoma. J. Proteomics 74, 1002–1014, doi:10.1016/j.jprot.2011.04.013 (2011). · DOI
- Wirsching, H. G. et al. Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma. Brain 137, 433–448, doi:10.1093/brain/awt333 (2014). · DOI
- Huret, J. L. et al. Atlas of genetics and cytogenetics in oncology and haematology in 2013. Nucleic Acids Res. 41, 920–924, doi:10.1093/nar/gks1082 (2013). · DOI · Paper page
- Nipp, M. et al. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging. J. Mol. Med. 90, 163–174, doi:10.1007/s00109-011-0815-6 (2012). · DOI
- McNamara, M., Sahebjam, S. & Mason, W. Emerging Biomarkers in Glioblastoma. Cancers (Basel). 5, 1103–1119 (2013). · DOI
- Barnard, G. F. et al. Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer. BBA - Mol. Basis Dis. 1272, 147–153, doi:10.1016/0925-4439(95)00079-8 (1995). · doi:10.1016/0925-4439(95)00079-8
- Lai, M. D. & Xu, J. Ribosomal proteins and colorectal cancer. Curr Genomics 8, 43–49, doi:10.2174/138920207780076938 (2007). · DOI
- Mi, H., Muruganujan, A., Casagrande, J. T. & Thomas, P. D. Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551–1566, doi:10.1038/nprot.2013.092 (2013). · DOI · Paper page
- Hanahan, D. & Weinberg, R. a. Hallmarks of cancer: The next generation. Cell 144, 646–674, doi:10.1016/j.cell.2011.02.013 (2011). · DOI · Paper page
- Wolf, A., Agnihotri, S. & Guha, A. Targeting metabolic remodeling in glioblastoma multiforme. Oncotarget 1, 552–562, doi:10.18632/oncotarget.101014 (2010). · DOI · Paper page
- Seyfried, T. N., Flores, R. E., Poff, A. M. & D’Agostino, D. P. Cancer as a metabolic disease: Implications for novel therapeutics. Carcinogenesis 35, 515–527, doi:10.1093/carcin/bgt480 (2014). · DOI · Paper page
- Kucharzewska, P., Christianson, H. C. & Belting, M. Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells. PLoS One 10, e0116740, doi:10.1371/journal.pone.0116740 (2015). · DOI · Paper page
- Wishart, D. S. Applications of metabolomics in drug discovery and development. Drugs R D 9, 307–322, doi:10.2165/00126839-200809050-00002 (2008). · DOI · Paper page
- Chinnaiyan, P. et al. The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res. 72, 5878–5888, doi:10.1158/0008-5472.CAN-12-1572-T (2012). · DOI · Paper page
- Hattori, K. et al. Paradoxical ATP elevation in ischemic penumbra revealed by quantitative imaging mass spectrometry. Antioxid. Redox Signal. 13, 1157–1167, doi:10.1089/ars.2010.3290 (2010). · DOI
- Kang, S. et al. Molecular proteomics imaging of tumor interfaces by mass spectrometry. J. Proteome Res. 9, 1157–1164, doi:10.1021/pr900666q (2010). · DOI
- Vannini, E. et al. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function. Neuro. Oncol. 18, 1634–1643, doi:10.1093/neuonc/now114 (2016). · DOI
- Sugiura, Y., Honda, K., Kajimura, M. & Suematsu, M. Visualization and quantification of cerebral metabolic fluxes of glucose in awake mice. Proteomics 14, 829–838, doi:10.1002/pmic.v14.7-8 (2014). · DOI
- Enthaler, B. et al. Influence of various on-tissue washing procedures on the entire protein quantity and the quality of matrix-assisted laser desorption/ionization spectra. Rapid Commun. Mass Spectrom. 27, 878–884, doi:10.1002/rcm.6513 (2013). · doi:10.1002/rcm.6513
- de Graaf, E. L., Pellegrini, D. & McDonnell, L. A. A set of novel automated quantitative microproteomics protocols for small sample amounts and its application to kidney tissue substructures. J. Proteome Res 15, 4722–4730, doi:10.1021/acs.jproteome.6b00889 (2016). · DOI · Paper page
- McDonnell, La, Walch, A., Stoeckli, M. & Corthals, G. L. MSiMass list: A public database of identifications for protein MALDI MS imaging. J. Proteome Res. 13, 1138–1142, doi:10.1021/pr400620y (2014). · DOI
Cited by
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Taylor, M. J., Lukowski, J. K., & Anderton, C. R. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00439 · Cited by 302
Applications of metabolomics to study cancer metabolism
Kaushik, A. K., & DeBerardinis, R. J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.009 · Cited by 179
Metadata
- Authors
- Dilillo, M., Ait-Belkacem, R., Esteve, C., Pellegrini, D., Nicolardi, S., Costa, M., Vannini, E., Graaf, E. L. D., Caleo, M., & McDonnell, L. A.
- Venue
- Scientific Reports
- Published
- 2017-04-04
- Volume
- 7
- Issue
- 1
- Pages
- 603-603
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2598316694
- Cited by
- 172
- References
- 2
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma. https://app.cochat.ai/papers/10.1038/s41598-017-00703-w
- The paper
- Dilillo, M., Ait-Belkacem, R., Esteve, C., Pellegrini, D., Nicolardi, S., Costa, M., Vannini, E., Graaf, E. L. D., Caleo, M., & McDonnell, L. A. (2017). Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma. Scientific Reports. https://doi.org/10.1038/s41598-017-00703-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.